{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:03:08Z","timestamp":1789596188942,"version":"build-2803163510"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K23AI102639"],"award-info":[{"award-number":["K23AI102639"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background.<\/jats:title>\n                  <jats:p>Tuberculous meningitis (TBM) is the most devastating clinical presentation of infection with Mycobacterium tuberculosis; delayed initiation of effective antituberculosis therapy is associated with poor treatment outcomes. Our objective was to determine the relationship between drug resistance and 10-year mortality among patients with TBM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods.<\/jats:title>\n                  <jats:p>We conducted a retrospective cohort study of 324 patients with culture-confirmed TBM, susceptibility results reported for isoniazid and rifampin, and initiation of at least 2 antituberculosis drugs, reported to the tuberculosis registry in New York City between 1 January 1992 and 31 December 2001. Date of death was ascertained by matching the tuberculosis registry with death certificate data for 1992\u20132012 from the New York Office of Vital Statistics. Human immunodeficiency virus (HIV) status was ascertained by medical records review, matching with the New York City HIV Surveillance registry, and review of cause of death.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results.<\/jats:title>\n                  <jats:p>Among 257 TBM patients without rifampin-resistant isolates, isoniazid resistance was associated with mortality after the first 60 days of treatment when controlling for age and HIV infection (adjusted hazard ratio, 1.94 [95% confidence interval, 1.08\u20133.94]). Death occurred before completion of antituberculosis therapy in 63 of 67 TBM patients (94%) with rifampin-resistant disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions.<\/jats:title>\n                  <jats:p>Among patients with culture-confirmed TBM, we observed rapid early mortality in patients with rifampin-resistant isolates, and an independent association between isoniazid-resistant isolates and death after 60 days of therapy. These findings support the continued evaluation of rapid diagnostic techniques and the empiric addition of second-line drugs for patients with clinically suspected drug-resistant TBM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciw763","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T20:05:49Z","timestamp":1479326749000},"page":"401-407","source":"Crossref","is-referenced-by-count":41,"title":["Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort Study"],"prefix":"10.1093","volume":"64","author":[{"given":"Christopher","family":"Vinnard","sequence":"first","affiliation":[{"name":"Public Health Research Institute, New Jersey Medical School 1 , Newark, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"King","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control 2 , Queens,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal","family":"Munsiff","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine and Dentistry 3 , New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Crossa","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control 2 , Queens,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Iwata","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease Therapeutics, Kobe University 4 ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jotam","family":"Pasipanodya","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Research and Experimental Therapeutics, Baylor University 5 , Dallas, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Proops","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control 2 , Queens,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shama","family":"Ahuja","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control 2 , Queens,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,1,7]]},"reference":[{"key":"2024111411402356000_CIT0001","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S1474-4422(13)70168-6","article-title":"Tuberculous meningitis: more questions, still too few answers","volume":"12","author":"Thwaites","year":"2013","journal-title":"Lancet Neurol"},{"key":"2024111411402356000_CIT0002","doi-asserted-by":"crossref","first-page":"19184","DOI":"10.7448\/IAS.17.1.19184","article-title":"Meningitis in HIV-positive patients in sub-Saharan Africa: a review","volume":"17","author":"Veltman","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2024111411402356000_CIT0003","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/jech-2013-202525","article-title":"Tuberculous meningitis","volume":"68","author":"Van","year":"2014","journal-title":"J Epidemiol Community Health"},{"key":"2024111411402356000_CIT0004","volume-title":"Treatment of tuberculosis guidelines","author":"World Health Organization","edition":"4th ed"},{"key":"2024111411402356000_CIT0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1473-3099(12)70264-5","article-title":"Intensified regimen containing rifampin and moxifloxacin for tuberculous meningitis: an open-label, randomized controlled phase 2 trial","volume":"13","author":"Ruslami","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"2024111411402356000_CIT0006","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1056\/NEJMoa1507062","article-title":"Intensified antituberculosis therapy in adults with tuberculous meningitis","volume":"374","author":"Heemskerk","year":"2016","journal-title":"N Engl J Med"},{"key":"2024111411402356000_CIT0007","doi-asserted-by":"crossref","first-page":"276","DOI":"10.5588\/ijtld.14.0805","article-title":"Appropriate use of the Xpert MTB\/RIF assay in suspected tuberculous meningitis","volume":"19","author":"Boyles","year":"2015","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411402356000_CIT0008","doi-asserted-by":"crossref","first-page":"c4451","DOI":"10.1136\/bmj.c4451","article-title":"Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study","volume":"341","author":"Vinnard","year":"2010","journal-title":"BMJ"},{"key":"2024111411402356000_CIT0009","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1128\/AAC.00319-12","article-title":"Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis","volume":"56","author":"Tho","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2024111411402356000_CIT0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.tube.2010.07.002","article-title":"Cerebrospinal fluid concentrations of antituberculosis agents in adults and children","volume":"90","author":"Donald","year":"2011","journal-title":"Tuberculosis (Edinb)"},{"key":"2024111411402356000_CIT0011","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1086\/381973","article-title":"Multidrug-resistant tuberculous meningitis in KwaZulu-Natal, South Africa","volume":"38","author":"Patel","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2024111411402356000_CIT0012","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jinf.2011.07.005","article-title":"Multidrug resistant tuberculous meningitis in the United States, 1993\u20132005","volume":"63","author":"Vinnard","year":"2011","journal-title":"J Infect"},{"key":"2024111411402356000_CIT0013","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00042-07","article-title":"Central nervous system tuberculosis: pathogenesis and clinical aspects","volume":"21","author":"Rock","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"2024111411402356000_CIT0014","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.jocn.2010.01.006","article-title":"Neurological and systemic complications of tuberculous meningitis and its treatment at Auckland City Hospital, New Zealand","volume":"17","author":"Anderson","year":"2010","journal-title":"J Clin Neurosci"},{"key":"2024111411402356000_CIT0015","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1473-3099(14)70852-7","article-title":"Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis","volume":"14","author":"Chiang","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2024111411402356000_CIT0016","doi-asserted-by":"crossref","first-page":"e27821","DOI":"10.1371\/journal.pone.0027821","article-title":"Dexamethasone and long-term outcomes of tuberculous meningitis in Vietnamese adults and adolescents","volume":"6","author":"Torok","year":"2011","journal-title":"PLoS One"},{"key":"2024111411402356000_CIT0017","doi-asserted-by":"crossref","first-page":"e0133477","DOI":"10.1371\/journal.pone.0133477","article-title":"Tuberculous meningitis in children and adults: a 10-year retrospective comparative analysis","volume":"10","author":"Miftode","year":"2015","journal-title":"PLoS One"},{"key":"2024111411402356000_CIT0018","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jar.12191","article-title":"Mortality of people with intellectual and developmental disabilities from select US state disability service systems and medical claims data","volume":"28","author":"Lauer","year":"2015","journal-title":"J Appl Res Intellect Disabil"},{"key":"2024111411402356000_CIT0019","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S1473-3099(10)70138-9","article-title":"Tuberculous meningitis: a uniform case definition for use in clinical research","volume":"10","author":"Marais","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"2024111411402356000_CIT0020","first-page":"1138","article-title":"Antibacterial susceptibility tests: mycobacteria","volume-title":"Manual of clinical microbiology","author":"Hawkins","year":"1991","edition":"5th ed"},{"key":"2024111411402356000_CIT0021","volume-title":"Public health mycobacteriology: a guide for the level III laboratory","author":"Kent","year":"1985"},{"key":"2024111411402356000_CIT0022","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM199203053261004","article-title":"Tuberculous meningitis in patients infected with the human immunodeficiency virus","volume":"326","author":"Berenguer","year":"1992","journal-title":"N Engl J Med"},{"key":"2024111411402356000_CIT0023","doi-asserted-by":"crossref","first-page":"b5087","DOI":"10.1136\/bmj.b5087","article-title":"Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes","volume":"340","author":"L\u00e9vesque","year":"2010","journal-title":"BMJ"},{"key":"2024111411402356000_CIT0024","first-page":"1613","article-title":"Achieving international targets for tuberculosis treatment success among HIV-positive patients in New York City","volume":"14","author":"King","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2024111411402356000_CIT0025","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/652654","article-title":"Changing sociodemographic and clinical characteristics of tuberculosis among HIV-infected patients, New York City, 1992\u20132005","volume":"50","author":"Harris","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2024111411402356000_CIT0026","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"The impact of confounder selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am J Epidemiol"},{"key":"2024111411402356000_CIT0027","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1146\/annurev.publhealth.18.1.105","article-title":"Survival analysis in public health research","volume":"18","author":"Lee","year":"1997","journal-title":"Annu Rev Public Health"},{"key":"2024111411402356000_CIT0028","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/jnci\/djg052","article-title":"Comparing survival of a sample to that of a standard population","volume":"95","author":"Finkelstein","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"2024111411402356000_CIT0029","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/516146","article-title":"Rifampin-monoresistant tuberculosis in New York City, 1993\u20131994","volume":"25","author":"Munsiff","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2024111411402356000_CIT0030","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1128\/AAC.05792-11","article-title":"A semimechanistic pharmacokinetic-enzyme turnover model for rifampin autoinduction in adult tuberculosis patients","volume":"56","author":"Smythe","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2024111411402356000_CIT0031","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1164\/rccm.200903-0439OC","article-title":"Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial","volume":"181","author":"Swaminathan","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"2024111411402356000_CIT0032","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJMoa040573","article-title":"Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults","volume":"351","author":"Thwaites","year":"2004","journal-title":"N Engl J Med"},{"key":"2024111411402356000_CIT0033","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1128\/JCM.01834-13","article-title":"Evaluation of GeneXpert MTB\/RIF for diagnosis of tuberculous meningitis","volume":"52","author":"Nhu","year":"2014","journal-title":"J Clin Microbiol"},{"key":"2024111411402356000_CIT0034","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/0974-777X.150882","article-title":"Evaluation of genotype MTBDRplus line probe assay for early detection of drug resistance in tuberculous meningitis patients in India","volume":"7","author":"Gupta","year":"2015","journal-title":"J Glob Infect Dis"},{"key":"2024111411402356000_CIT0035","doi-asserted-by":"crossref","first-page":"7104","DOI":"10.1128\/AAC.01117-15","article-title":"Sensititre MycoTB plate compared to Bactec MGIT 960 for first- and second-line antituberculosis drug susceptibility testing in Tanzania: a call to operationalize MICs","volume":"59","author":"Heysell","year":"2015","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/401\/24254651\/ciw763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/64\/4\/401\/24254651\/ciw763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:50:58Z","timestamp":1731585058000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/64\/4\/401\/2631869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,7]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,1,7]]},"published-print":{"date-parts":[[2017,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciw763","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,2,15]]},"published":{"date-parts":[[2017,1,7]]}}}